Pelvic organ prolapse (POP) is non-fatal conditions which can markedly affect a patient's quality of life. Multiple recently developed pelvic reconstructive surgeries have led to a recent expansion in China. In this study, we would like to discuss various aspects of the evaluation and management of POP and raise the question of what is sufficient evidence for the adoption of innovative treatments for POP.
China ; epidemiology ; Female ; Humans ; Pelvic Organ Prolapse ; diagnosis ; epidemiology ; surgery